Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 5/20 | 0.60 |
| ▸ | CA2 | P00918 | 5/20 | 0.60 |
| ▸ | CES2 | O00748 | 2/20 | 0.56 |
| ▸ | CES1 | P23141 | 2/20 | 0.56 |
| ▸ | CA12 | O43570 | 1/20 | 0.55 |
| ▸ | CA7 | P43166 | 1/20 | 0.55 |
| ▸ | CA9 | Q16790 | 1/20 | 0.55 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.55 |
| ▸ | GAA | P10253 | 1/20 | 0.55 |
| ▸ | HTT | P42858 | 1/20 | 0.55 |
| ▸ | PARP1 | P09874 | 1/20 | 0.52 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.52 |
| ▸ | PARP2 | Q9UGN5 | 1/20 | 0.52 |
| ▸ | PARP4 | Q9UKK3 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | RAB9A | P51151 | 2/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL11840046 | 0.98 | CA1 (0.58) | CA1CA2CES2CES1CA12 | |
| SCHEMBL8991731 | 0.95 | GAA (0.56) | CA1CA2CES2CES1CA12 | |
| SCHEMBL6223461 | 0.93 | ESR2 (0.56) | CA1CA2CES2CES1CA12 | |
| Guanidine SCHEMBL7470320 | 0.89 | CA1 (0.53) | CA1CA2CES2CES1SMN1; SMN2 | |
| SCHEMBL18363037 | 0.88 | LMNA (0.66) | CA1CA2CES2CES1SMN1; SMN2 | |
| SCHEMBL1690741 | 0.88 | LMNA (0.66) | CA1CA2CES2CES1SMN1; SMN2 | |
| SCHEMBL465132 | 0.87 | LMNA (0.52) | SMN1; SMN2ALDH1A1GAAHTTLMNA | |
| SCHEMBL17248001 | 0.86 | MAPT (0.49) | CA1CA2CES2CES1SMN1; SMN2 | |
| Acetic Acid SCHEMBL1868800 | 0.86 | LMNA (0.61) | CA1CA2CES2CES1CA12 | |
| SCHEMBL1871227 | 0.85 | LMNA (0.67) | CA1CA2CES2CES1CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1245 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114316096-A | Functionalized polyolefin elastomer and preparation method thereof | 常州汉韦聚合物有限公司 | 2022-04-12 | — | — | CN | claimed |
| EP-2154138-B1 | NOVEL COMPOUNDS FOR TREATMENT OF PSYCHOTIC DISORDERS, PREPARATION METHODS AND USES THEREOF | LI YOUXIN (CN) | 2015-08-19 | — | — | EP | claimed |
| CN-118591539-A | Substituted thiazolidinedione derivative compounds and pharmaceutical composition for preventing or treating cancer comprising the same | (株)美迪菲 | 2024-09-03 | — | — | CN | disclosed |
| CN-118202006-A | Resin composition, cured product, optical member, ultraviolet absorber, compound, method for producing compound, and polymer | 富士胶片株式会社 | 2024-06-14 | — | — | CN | disclosed |
| CN-118176445-A | Light absorbing filter, light filter, method for manufacturing light absorbing filter, organic electroluminescent display device, inorganic electroluminescent display device, and liquid crystal display device | 富士胶片株式会社 | 2024-06-11 | — | — | CN | disclosed |
| US-11993697-B2 | Flexible tube for endoscope, endoscopic medical device, and resin composition for covering flexible tube substrate for endoscope | FUJIFILM CORPORATION (JP) | 2024-05-28 | — | — | US | disclosed |
| US-20240150359-A1 | COMPOUNDS AND METHODS FOR TREATMENT OF VIRAL INFECTIONS | GILEAD SCIENCES, INC. | 2024-05-09 | — | — | US | disclosed |
| WO-2024085171-A1 | LIGHT ABSORPTION FILTER, OPTICAL FILTER AND METHOD FOR PRODUCING SAME, ORGANIC ELECTROLUMINESCENT DISPLAY DEVICE, INORGANIC ELECTROLUMINESCENT DISPLAY DEVICE, AND LIQUID CRYSTAL DISPLAY DEVICE | 富士フイルム株式会社 | 2024-04-25 | — | — | WO | disclosed |
| WO-2024085172-A1 | LIGHT ABSORPTION FILTER, OPTICAL FILTER AND METHOD FOR PRODUCING SAME, ORGANIC ELECTROLUMINESCENT DISPLAY DEVICE, INORGANIC ELECTROLUMINESCENT DISPLAY DEVICE, AND LIQUID CRYSTAL DISPLAY DEVICE | 富士フイルム株式会社 | 2024-04-25 | — | — | WO | disclosed |
| US-11958959-B2 | Lens for spectacles and spectacles | FUJIFILM CORPORATION (JP) | 2024-04-16 | — | — | US | disclosed |
| WO-2024062843-A1 | COLORED COMPOSITION, COLORED PRODUCT, AND COMPOUND | 富士フイルム株式会社 | 2024-03-28 | — | — | WO | disclosed |
| EP-0180188-B1 | A COMPOSITION FOR INCREASING THE ANTI-CANCER ACTIVITY OF AN ANTI-CANCER COMPOUND | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1992-04-15 | — | — | EP | disclosed |
| US-4983609-A | Anticancer agents | OTSUKA PHARMACEUTICAL (JP) | 1991-01-08 | — | — | US | disclosed |
| US-4914206-A | ANTIBIOTICS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1990-04-03 | — | — | US | disclosed |
| US-4864021-A | ANTICARCINOGENIC AGENTS, ANTITUMOR AGENTS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1989-09-05 | — | — | US | disclosed |
| EP-0323441-A2 | 5-Fluorouracil derivatives | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1989-07-05 | — | — | EP | disclosed |
| EP-0226896-A2 | Lankacidin derivatives and production thereof | Takeda Chemical Industries, Ltd. (JP) | 1987-07-01 | — | — | EP | disclosed |
| EP-0180188-A2 | A composition for increasing the anti-cancer activity of an anti-cancer compound | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1986-05-07 | — | — | EP | disclosed |
| US-4182726-A | FROM THE PHENOL OR ESTER OF THE PHENOL | SNAMPROGETTI, S.P.A. (IT) | 1980-01-08 | — | — | US | disclosed |
| US-3989710-A | POSTEMERGENCE HERBICIDES | BAYER AKTIENGESELLSCHAFT (DT) | 1976-11-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240150359-A1 | COMPOUNDS AND METHODS FOR TREATMENT OF VIRAL INFECTIONS | HAVCR2, EIF2AK2, OAT | CA1 1982/4885CA2 1878/4885CES2 205/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.